-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
3 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$20.57 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$2.36 M
EyePoint Pharmaceuticals, Inc. Insider Transactions
EyePoint Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
GUYER DAVID R
Director |
Sell | 11,625 @ $10.30 | $119,705 | 3,700 | 06/03/2024 | 06/04/2024 | |
|
GUYER DAVID R
Director |
Sell | 11,625 @ $12.65 | $147,045 | 5,550 | 05/14/2024 | 05/16/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 642,847 @ $11.70 | $7.52 M | 8,117,847 | 05/06/2024 | 05/08/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 207,153 @ $12.36 | $2.56 M | 8,325,000 | 05/06/2024 | 05/08/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 186,521 @ $18.90 | $3.53 M | 7,475,000 | 04/18/2024 | 04/22/2024 | |
|
Cormorant Asset Management, LP
10 percent owner |
Buy | 395,244 @ $17.62 | $6.96 M | 7,288,479 | 04/18/2024 | 04/22/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 209 @ $28.49 | $5,954 | 37,962 | 02/02/2024 | 02/05/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 51 @ $25.41 | $1,296 | 85,779 | 01/26/2024 | 01/30/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 15,609 @ $25.41 | $396,572 | 70,170 | 01/26/2024 | 01/30/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 33,665 @ $25.77 | $867,672 | 36,505 | 01/26/2024 | 01/30/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 16,413 @ $25.45 | $417,653 | 47,566 | 01/26/2024 | 01/29/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 9,604 @ $25.27 | $242,717 | 37,962 | 01/26/2024 | 01/29/2024 | |
|
Paggiarino Dario A.
Chief Medical Officer |
Sell | 300 @ $25.00 | $7,500 | 36,505 | 01/25/2024 | 01/29/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 300 @ $25.00 | $7,500 | 37,962 | 01/25/2024 | 01/26/2024 | |
|
Jones David Scott
SVP & Chief Commercial Officer |
Sell | 5,700 @ $25.01 | $142,554 | 43,562 | 01/24/2024 | 01/26/2024 |
EyePoint Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on EyePoint Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at EyePoint Pharmaceuticals, Inc. includes Jones David Scott, Paggiarino Dario A., Cormorant Asset Management, LP, GUYER DAVID R.
-
How much insider selling is happening at EyePoint Pharmaceuticals, Inc.?
Insiders have sold a total of 105,101 EyePoint Pharmaceuticals, Inc. shares in the last 12 months for a total of 2.36 M sold.
-
Which EyePoint Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold EyePoint Pharmaceuticals, Inc. shares in the last 12 months: Jones David Scott ($816,378), Paggiarino Dario A. ($1.27 M), GUYER DAVID R ($266,750),
-
How much insider buying is happening at EyePoint Pharmaceuticals, Inc.?
Insiders have purchased a total of 1.43 M EyePoint Pharmaceuticals, Inc. shares in the last 12 months for a total of 20.57 M sold.
-
Which EyePoint Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased EyePoint Pharmaceuticals, Inc. shares in the last 12 months: Cormorant Asset Management, LP ($20.57 M),